Telehealth Co. Cardiocom Faces Patent Suit, Denies Claims

Robert Bosch Healthcare Systems claims that Chanhassen-based Cardiocom infringed on six of its patents, but Cardiocom denied the allegations.

A competitor is accusing Chanhassen-based telehealth products and services provider Cardiocom, LLC, of patent infringement, but the company on Monday denied any wrongdoing.

Palo Alto, California-based Robert Bosch Healthcare Systems, Inc., filed a lawsuit last week, alleging that the Cardiocom Telehealth system, a remote health monitoring system, infringes on six of its patents, according to court documents filed in U.S. District Court in California.

The six patents named in the suit are related to methods and devices used to securely transmit medical data and communication via the Internet or cell phones.

Daniel Cosentino, Cardiocom’s president and CEO, said in a statement that Robert Bosch’s claims are “groundless and completely without merit” and that Cardiocom’s products and services do not violate any intellectual property rights.

The Cardiocom Telehealth system allows doctors and nurses to collect data, such as patients’ vital signs, remotely through the Web or via cell phones. It also allows doctors to hold remote sessions with patients and send them medication reminders.

Robert Bosch’s lawsuit seeks to permanently stop Cardiocom from making and selling the system and to recover unspecified damages that it suffered due to Cardiocom’s “infringing activities.”

Cardiocom has about three weeks to file a response or a motion in court.